Results
182
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
182 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$26.56 | -6.8% | 65.8% | US$4.6b | US$32.17 | PS22.7x | E60.9% | n/a | Semiconductors | ||
EH | US$12.21 | -1.7% | -43.7% | US$807.5m | US$24.98 | PS35.7x | E74.3% | n/a | Capital Goods | ||
ATAT | US$15.72 | -5.4% | -25.1% | US$2.3b | US$26.42 | PE16x | E21.9% | 1.0% | Consumer Services | ||
TBBB | US$27.05 | 3.4% | n/a | US$3.0b | US$26.84 | PS1.2x | E94.7% | n/a | Consumer Retailing | ||
VCTR | US$50.19 | -4.7% | 54.1% | US$3.4b | US$52.00 | PE14.8x | E32.3% | 2.9% | Diversified Financials | ||
GCT | US$27.44 | 2.5% | 191.9% | US$1.2b | US$52.57 | PE10.7x | E24.7% | n/a | Retail | ||
PDD | US$127.82 | -1.5% | 43.9% | US$179.0b | US$207.40 | PE16.1x | E21.6% | n/a | Retail | ||
CG | US$47.76 | 3.1% | 50.9% | US$17.9b | US$48.30 | PS7.7x | E23.6% | 2.9% | Diversified Financials | ||
SMCI | US$672.24 | -3.4% | 109.3% | US$41.1b | US$1,033.54 | PE37.5x | E39.0% | n/a | Tech | ||
DUOL | US$164.50 | -2.3% | 16.5% | US$7.4b | US$250.46 | PE155.5x | E47.9% | n/a | Consumer Services | ||
BRDG | US$7.71 | -2.3% | -36.6% | US$986.0m | US$9.88 | PB3.6x | E98.2% | 8.6% | Diversified Financials | ||
MAX | US$16.59 | 14.9% | 76.3% | US$1.0b | US$24.67 | PS1.8x | E79.8% | n/a | Media | ||
ZKH | US$2.83 | -9.3% | n/a | US$481.6m | US$15.74 | PB1x | E104.4% | n/a | Capital Goods | ||
HSAI | US$4.31 | 0.2% | -63.7% | US$566.0m | US$10.06 | PS2.2x | E71.0% | n/a | Automobiles | ||
BMRC | US$19.18 | -12.9% | -9.8% | US$328.4m | US$21.60 | PB0.7x | E165.0% | 5.2% | Banks | ||
SMSI | US$2.48 | 0% | -72.6% | US$26.0m | US$10.67 | PB0.6x | E81.8% | n/a | Software | ||
NEON | US$2.81 | -6.3% | 21.1% | US$45.9m | US$3.00 | PS10.3x | E158.0% | n/a | Tech | ||
MDGL | US$278.48 | -1.8% | 44.1% | US$6.1b | US$365.33 | PB7x | E64.4% | n/a | Pharmaceuticals & Biotech | ||
WULF | US$4.11 | -9.3% | 50.5% | US$1.4b | US$6.84 | PS13.7x | E99.5% | n/a | Software | ||
ALKT | US$33.86 | 4.3% | 105.7% | US$3.2b | US$32.60 | PS11.3x | E103.5% | n/a | Software | ||
SMWB | US$6.34 | -7.0% | -11.7% | US$492.3m | US$10.40 | PS2.3x | E107.1% | n/a | Software | ||
RYAN | US$62.51 | 5.8% | 41.1% | US$16.0b | US$60.68 | PE117x | E49.2% | 0.7% | Insurance | ||
EVOK | US$4.86 | -16.0% | -74.4% | US$3.4m | US$84.00 | PB1x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
MYO | US$4.42 | -9.1% | 563.1% | US$137.2m | US$6.83 | PS6.5x | E68.9% | n/a | Healthcare |